Citation Impact
Citing Papers
Species Interactions in a Parasite Community Drive Infection Risk in a Wildlife Population
2010 StandoutScience
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Cell entry mechanisms of SARS-CoV-2
2020 Standout
Proteomics of HCV virions reveals an essential role for the nucleoporin Nup98 in virus morphogenesis
2016 StandoutNobel
Deciphering O -glycoprotease substrate preferences with O-Pair Search
2022 StandoutNobel
The Interferon-Inducible Host Factor Bone Marrow Stromal Antigen 2/Tetherin Restricts Virion Release, but Is It Actually a Viral Restriction Factor?
2010
Membrane curvature regulates the spatial distribution of bulky glycoproteins
2022 StandoutNobel
Identification of interferon-stimulated genes that attenuate Ebola virus infection
2020 StandoutNobel
Characterization of HIV-1 Nucleoside-Modified mRNA Vaccines in Rabbits and Rhesus Macaques
2019 StandoutNobel
Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation
2015
Native‐like Env trimers as a platform for HIV ‐1 vaccine design
2017
Intrinsic Cellular Defenses against Human Immunodeficiency Viruses
2012
Influenza Virus Partially Counteracts Restriction Imposed by Tetherin/BST-2
2012
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
2017 Standout
A robust cell culture system supporting the complete life cycle of hepatitis B virus
2017 StandoutNobel
O-Pair Search with MetaMorpheus for O-glycopeptide characterization
2020 StandoutNobel
Virus-like particles in vaccine development
2010
CRISPR–Cas9 genome engineering of primary CD4+ T cells for the interrogation of HIV–host factor interactions
2018 StandoutNobel
High‐Dose Recombinant Canarypox Vaccine Expressing HIV‐1 Protein, in Seronegative Human Subjects
2005
Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways
2015
HIV-1 Vpu — an ion channel in search of a job
2013
Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160ΔV1V2 is strongly immunogenic
2009
Membrane vesicles as conveyors of immune responses
2009 Standout
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes
2006
Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells
2004
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Clinical and immunological features of severe and moderate coronavirus disease 2019
2020 Standout
Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120
2006
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
2020 Standout
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
2006
Revealing the human mucinome
2022 StandoutNobel
The Restriction Factors of Human Immunodeficiency Virus
2012
Glycosylation in health and disease
2019
Poxvirus tropism
2005
HIV Restriction Factors and Mechanisms of Evasion
2012
Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine
2013 StandoutNobel
Maturation-Induced Cloaking of Neutralization Epitopes on HIV-1 Particles
2011
A Blueprint for HIV Vaccine Discovery
2012
Inhibition of HIV-1 Particle Assembly by 2′,3′-Cyclic-Nucleotide 3′-Phosphodiesterase
2012 StandoutNobel
DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant
2005
Increased surface expression of HIV-1 envelope is associated with improved antibody response in vaccinia prime/protein boost immunization
2017 StandoutNobel
Stabilization of HIV-1 gp120-CD4 Receptor Complex through Targeted Interchain Disulfide Exchange
2010
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
2020 Standout
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
BST-2/tetherin: Structural biology, viral antagonism, and immunobiology of a potent host antiviral factor
2012
Identification of Interferon-Stimulated Genes with Antiretroviral Activity
2016 StandoutNobel
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
2013
Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
2018 Standout
Interferon-stimulated genes and their antiviral effector functions
2011 StandoutNobel
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Antiretroviral restriction factors
2011
Virus-like particles: Designing an effective AIDS vaccine
2006
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Glycoproteomics
2022 StandoutNobel
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
2007
Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates
2006
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
2013 StandoutScienceNobel
Broadly Neutralizing Immune Responses against Hepatitis C Virus Induced by Vectored Measles Viruses and a Recombinant Envelope Protein Booster
2012 StandoutNobel
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance
2016 StandoutNobel
Electron-Based Dissociation Is Needed for O-Glycopeptides Derived from OpeRATOR Proteolysis
2020 StandoutNobel
Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures
2007 Standout
Interferon-Induced SCYL2 Limits Release of HIV-1 by Triggering PP2A-Mediated Dephosphorylation of the Viral Protein Vpu
2012
Neutralizing antibodies to HIV-1 induced by immunization
2013
Interferon-Stimulated Genes: A Complex Web of Host Defenses
2014 StandoutNobel
Viral interactions with host cell Rab GTPases
2017
Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity
2016
Truncation of the Membrane-Spanning Domain of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Defines Elements Required for Fusion, Incorporation, and Infectivity
2009
Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1
2011 StandoutNobel
Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms
2010
Poxviruses and Immune Evasion
2003
Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
2023 StandoutNobel
Design of a hyperstable 60-subunit protein icosahedron
2016 StandoutNatureNobel
Characterization of the Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Conformational States on Infectious Virus Particles
2023
Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo
2011
C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1
2012 StandoutNobel
HIV-1 Virus-Like Particles Bearing Pure Env Trimers Expose Neutralizing Epitopes but Occlude Nonneutralizing Epitopes
2012
Works of J. Hammonds being referenced
Advances in methods for the production, purification, and characterization of HIV-1 Gag–Env pseudovirion vaccines
2007
Pseudovirion Particles Bearing Native HIV Envelope Trimers Facilitate a Novel Method for Generating Human Neutralizing Monoclonal Antibodies Against HIV
2010
Immunoelectron Microscopic Evidence for Tetherin/BST2 as the Physical Bridge between HIV-1 Virions and the Plasma Membrane
2010
Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core
2003
Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1
2017
Tetherin/BST-2 Is Essential for the Formation of the Intracellular Virus-Containing Compartment in HIV-Infected Macrophages
2012
Expression of Vaccinia E3L and K3L Genes by a Novel Recombinant Canarypox HIV Vaccine Vector Enhances HIV-1 Pseudovirion Production and Inhibits Apoptosis in Human Cells
2001
A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type– and Rab11-FIP1C–dependent incorporation into virions
2015
Induction of Neutralizing Antibodies against Human Immunodeficiency Virus Type 1 Primary Isolates by Gag-Env Pseudovirion Immunization
2005
Pseudovirion Particle Production by Live Poxvirus Human Immunodeficiency Virus Vaccine Vector Enhances Humoral and Cellular Immune Responses
2005
The Tetherin/BST-2 Coiled-Coil Ectodomain Mediates Plasma Membrane Microdomain Localization and Restriction of Particle Release
2011